Open Access

[Corrigendum] Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury

  • Authors:
    • Jinshi Zhang
    • Wenfang He
    • Danna Zheng
    • Qiang He
    • Mingming Tan
    • Juan Jin
  • View Affiliations

  • Published online on: May 31, 2022     https://doi.org/10.3892/mmr.2022.12757
  • Article Number: 241
  • Copyright : © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

July-2022
Volume 26 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang J, He W, Zheng D, He Q, Tan M and Jin J: [Corrigendum] Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury. Mol Med Rep 26: 241, 2022.
APA
Zhang, J., He, W., Zheng, D., He, Q., Tan, M., & Jin, J. (2022). [Corrigendum] Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury. Molecular Medicine Reports, 26, 241. https://doi.org/10.3892/mmr.2022.12757
MLA
Zhang, J., He, W., Zheng, D., He, Q., Tan, M., Jin, J."[Corrigendum] Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury". Molecular Medicine Reports 26.1 (2022): 241.
Chicago
Zhang, J., He, W., Zheng, D., He, Q., Tan, M., Jin, J."[Corrigendum] Exosomal‑miR‑1184 derived from mesenchymal stem cells alleviates cisplatin‑associated acute kidney injury". Molecular Medicine Reports 26, no. 1 (2022): 241. https://doi.org/10.3892/mmr.2022.12757